Skip to content
2000
Volume 6, Issue 13
  • ISSN: 1568-0266
  • E-ISSN: 1873-4294

Abstract

Antagonists for the Histamine H 1 receptor have been on the market for decades and continue to be successfully used in the treatment of a variety of allergic conditions. The recently discovered histamine H4 receptor subtype is emerging as a new and complementary target for treating inflammatory conditions. In this review, we describe the receptor protein, its putative role in (patho)physiology and the latest ligands that are being developed to explore the feasibility of the H4 receptor as a drug target.

Loading

Article metrics loading...

/content/journals/ctmc/10.2174/15680266106061365
2006-07-01
2025-09-14
Loading full text...

Full text loading...

/content/journals/ctmc/10.2174/15680266106061365
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test